Speyside Equity (“Speyside”) is pleased to announce that it has acquired the majority of Oxxynova GmbH (“Oxxynova”), a German chemical company that predominantly produces and markets dimethyl terephthalate (“DMT”) for the European polyester industry.
Oxxynova, located in Steyerberg, Germany and established through the former Dynamit Nobel AG, has been producing liquid DMT since 1977. The Company has established itself as the leading manufacturer of DMT through proprietary technology and by mastering the Witten-Katzschmann method. Oxxynova produces high purity and outstanding quality liquid DMT used in the polyester fiber industry throughout Europe. The Company also produces various DMT-related xylol derivatives to be marketed for special use and is involved in the development and disposal of chemical by-products.
Commenting on the acquisition, Speyside partner Oliver Maier said: “We are excited to announce our acquisition of Oxxynova. The Company has established itself as a leader in the DMT market and in Europe and continues to innovate in this and related fields. This acquisition is a great fit within Speyside’s focus on the specialty chemical industry. We have created a great partnership with Oxxynova and look forward to helping the management team continue its successful track record.”
For further information, please contact:
1500 Broadway, Suite 810
New York, NY 10036
T: +1 212 994 0308 x 208
About Speyside Equity:
Speyside Equity invests in middle-market industrial businesses with a history of profitability and strong market positions. It has a focus on the industrials, chemicals and food sectors with an affinity for cross-border deals, and spin-offs of large multinationals. Target investments are typically headquartered in developed markets in the United States and Europe, and valued at US$20-200 million.